Emergent BioSolutions Inc.EBSNYSE
LOADING
|||
Operating Income Contraction
Trending higher, below historical average.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-108.70M
↓ 411% below average
Average (9y)
$35.00M
Historical baseline
Range
High:$438.50M
Low:$-726.40M
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $-108.70M | +85.0% |
| 2023 | $-726.40M | -327.3% |
| 2022 | $-170.00M | -149.8% |
| 2021 | $341.40M | -22.1% |
| 2020 | $438.50M | +284.3% |
| 2019 | $114.10M | +27.1% |
| 2018 | $89.80M | -27.8% |
| 2017 | $124.30M | +17.8% |
| 2016 | $105.50M | -25.4% |
| 2015 | $141.51M | - |